-Mesoblast Limited - First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS

Media coverage

• Title	-Mesoblast Limited - First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS
  Media name/outlet	ENP Newswire
  Country/Territory	United Kingdom
  Date	7/05/20
  Persons	Alan Moskowitz, Emilia Bagiella, Annetine Gelijns

• Title	MESOBLAST LIMITED : - First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS
  Media name/outlet	MarketScreener.com
  Country/Territory	United States
  Date	7/05/20
  URL	https://www.marketscreener.com/MESOBLAST-LIMITED-6499027/news/Mesoblast-Limited-First-Patients-Dosed-in-Phase-2-3-Trial-for-COVID-19-ARDS-30556751/
  Persons	Alan Moskowitz, Emilia Bagiella, Annetine Gelijns